Sumit Arora

7.0k total citations · 3 hit papers
80 papers, 5.6k citations indexed

About

Sumit Arora is a scholar working on Molecular Biology, Cancer Research and Pharmaceutical Science. According to data from OpenAlex, Sumit Arora has authored 80 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Cancer Research and 13 papers in Pharmaceutical Science. Recurrent topics in Sumit Arora's work include MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (9 papers) and Innovative concrete reinforcement materials (9 papers). Sumit Arora is often cited by papers focused on MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (9 papers) and Innovative concrete reinforcement materials (9 papers). Sumit Arora collaborates with scholars based in United States, India and United Kingdom. Sumit Arora's co-authors include Kishore M. Paknikar, Muhammad Wahajuddin, Jyutika M. Rajwade, Ajay P. Singh, Seema Singh, Sanjeev K. Srivastava, Arun Bhardwaj, S. P. Singh, Sharanjot Saini and Varahram Shahryari and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sumit Arora

79 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers

2012 837 citations Muhammad Wahajuddin, Sumit Arora International Journal of Nanomedicine profile →
Cellular responses induced by silver nanoparticles: In vitro studies

2008 588 citations Sumit Arora et al. profile →
Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use

2009 500 citations Sumit Arora et al. Molecular Pharmaceutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sumit Arora United States	35	1.9k	1.7k	1.1k	1.1k	902	80	5.6k
Seung Bum Park South Korea	51	3.5k 1.8×	2.0k 1.1×	1.3k 1.2×	343 0.3×	836 0.9×	247	9.6k
Huijie Zhang China	38	1.4k 0.7×	1.9k 1.1×	1.4k 1.2×	244 0.2×	842 0.9×	246	5.9k
Lei Dong China	52	2.8k 1.5×	649 0.4×	1.7k 1.5×	744 0.7×	1.1k 1.2×	221	8.4k
Xiaolong Zhang China	49	4.8k 2.5×	1.6k 0.9×	1.6k 1.4×	580 0.5×	398 0.4×	270	8.5k
Linhua Zhang China	35	2.2k 1.2×	365 0.2×	825 0.7×	630 0.6×	495 0.5×	165	5.1k
Tingting Wang China	36	1.8k 1.0×	1.1k 0.6×	2.0k 1.8×	231 0.2×	691 0.8×	186	5.1k
Yan Zhang China	42	1.8k 1.0×	1.3k 0.8×	646 0.6×	268 0.2×	636 0.7×	272	6.2k
Yi Cao China	43	1.7k 0.9×	1.3k 0.8×	1.4k 1.2×	534 0.5×	777 0.9×	238	5.3k
Na Wang China	40	1.9k 1.0×	1.2k 0.7×	1.9k 1.7×	223 0.2×	1.2k 1.3×	284	5.8k
Huijun Zhu China	34	1.7k 0.9×	920 0.5×	347 0.3×	573 0.5×	533 0.6×	135	4.5k

Countries citing papers authored by Sumit Arora

Since Specialization

Citations

This map shows the geographic impact of Sumit Arora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumit Arora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumit Arora more than expected).

Fields of papers citing papers by Sumit Arora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumit Arora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumit Arora. The network helps show where Sumit Arora may publish in the future.

Co-authorship network of co-authors of Sumit Arora

This figure shows the co-authorship network connecting the top 25 collaborators of Sumit Arora. A scholar is included among the top collaborators of Sumit Arora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumit Arora. Sumit Arora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thakur, Kanika, et al.. (2024). Development and verification of mechanistic vaginal absorption and metabolism model to predict systemic exposure after vaginal ring and gel application. British Journal of Clinical Pharmacology. 90(6). 1428–1449. 2 indexed citations

Mackie, Claire, Sumit Arora, Paul Seo, et al.. (2024). Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary Report. Molecular Pharmaceutics. 21(5). 2065–2080. 24 indexed citations

Arora, Sumit, James F. Clarke, Eleftheria Tsakalozou, et al.. (2022). Mechanistic Modeling of In Vitro Skin Permeation and Extrapolation to In Vivo for Topically Applied Metronidazole Drug Products Using a Physiologically Based Pharmacokinetic Model. Molecular Pharmaceutics. 19(9). 3139–3152. 13 indexed citations

Arora, Sumit, Amita Pansari, Peter Kilford, et al.. (2020). Biopharmaceutic In Vitro In Vivo Extrapolation (IVIV_E) Informed Physiologically-Based Pharmacokinetic Model of Ritonavir Norvir Tablet Absorption in Humans Under Fasted and Fed State Conditions. Molecular Pharmaceutics. 17(7). 2329–2344. 26 indexed citations

Paudel, Amrit, Sarah Zellnitz, Sumit Arora, et al.. (2018). MODEL INFORMED DEVELOPMENT OF DRY POWDER INHALER (DPI) FORMULATIONS AND PROCESSES. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31(2). 1 indexed citations

Zubair, Haseeb, Shafquat Azim, Sanjeev K. Srivastava, et al.. (2016). Glucose Metabolism Reprogrammed by Overexpression of IKKϵ Promotes Pancreatic Tumor Growth. Cancer Research. 76(24). 7254–7264. 34 indexed citations

Arora, Sumit & S. P. Singh. (2015). Flexural Fatigue Analysis of Concrete made with 100% Recycled Concrete Aggregates. SHILAP Revista de lepidopterología. 13 indexed citations

Srivastava, Sanjeev K., Anuradha Bhardwaj, Sumit Arora, et al.. (2015). Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis. British Journal of Cancer. 112(11). 1772–1781. 49 indexed citations

Saini, Sharanjot, Shahana Majid, Varahram Shahryari, et al.. (2014). Regulation of SRC Kinases by microRNA-3607 Located in a Frequently Deleted Locus in Prostate Cancer. Molecular Cancer Therapeutics. 13(7). 1952–1963. 19 indexed citations

10.

Singh, Seema, Sanjeev K. Srivastava, Sumit Arora, et al.. (2014). Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model. British Journal of Cancer. 110(8). 2000–2010. 47 indexed citations

11.

Shlykov, Maksim A., Åke Västermark, Vamsee Reddy, et al.. (2013). The transporter–opsin– G protein‐coupled receptor ( TOG ) superfamily. FEBS Journal. 280(22). 5780–5800. 42 indexed citations

12.

Bhardwaj, Arun, Sumit Arora, Vijay Kumar Prajapati, Seema Singh, & Ajay P. Singh. (2013). Cancer “Stemness”- Regulating MicroRNAs: Role, Mechanisms and Therapeutic Potential. Current Drug Targets. 14(10). 1175–1184. 20 indexed citations

13.

Saini, Sharanjot, Shahana Majid, Varahram Shahryari, et al.. (2012). miRNA-708 Control of CD44+ Prostate Cancer–Initiating Cells. Cancer Research. 72(14). 3618–3630. 103 indexed citations

14.

Majid, Shahana, Altaf A. Dar, Sharanjot Saini, et al.. (2012). miRNA-34b Inhibits Prostate Cancer through Demethylation, Active Chromatin Modifications, and AKT Pathways. Clinical Cancer Research. 19(1). 73–84. 96 indexed citations

15.

Majid, Shahana, Altaf A. Dar, Sharanjot Saini, et al.. (2012). miR-23b Represses Proto-oncogene Src Kinase and Functions as Methylation-Silenced Tumor Suppressor with Diagnostic and Prognostic Significance in Prostate Cancer. Cancer Research. 72(24). 6435–6446. 125 indexed citations

16.

Wahajuddin, Muhammad & Sumit Arora. (2012). Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. International Journal of Nanomedicine. 7. 3445–3445. 837 indexed citations breakdown →

17.

Saini, Sharanjot, Sumit Arora, Shahana Majid, et al.. (2011). Curcumin Modulates MicroRNA-203–Mediated Regulation of the Src-Akt Axis in Bladder Cancer. Cancer Prevention Research. 4(10). 1698–1709. 173 indexed citations

18.

Zhang, Zilai, Sumit Arora, Yanjiao Zhou, Athena M. Cherry, & Teresa S.‐F. Wang. (2010). Replication-compromised cells require the mitotic checkpoint to prevent tetraploidization. Chromosoma. 120(1). 73–82. 2 indexed citations

19.

Bisht, Kamlesh, Sumit Arora, Shakil Ahmed, & Jagmohan Singh. (2008). Role of heterochromatin in suppressing subtelomeric recombination in fission yeast. Yeast. 25(8). 537–548. 9 indexed citations

20.

Ahmed, Shakil, Sharanjot Saini, Sumit Arora, & Jagmohan Singh. (2001). Chromodomain Protein Swi6-mediated Role of DNA Polymerase α in Establishment of Silencing in Fission Yeast. Journal of Biological Chemistry. 276(51). 47814–47821. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact